Physician profile
Bert C Hepner
NPI 1174521629
$3,902.58
in general payments reported to CMS, 2019-2025
20 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $121 · 2021: $1,137 · 2022: $17.76 · 2023: $2,100 · 2024: $148 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,487 · Food and Beverage: $946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,486.86 |
| Food and Beverage | $945.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,273.31 | 2020-2025 | Journey II, Real Intelligence, Redapt |
| Bioventus LLC | $101.74 | 2019-2025 | Xcell, Durolane, Exogen Ultrasound Bone Healing System |
| Ferring Pharmaceuticals INC. | $76.31 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $58.11 | 2019-2025 | Activbraid |
| Pacira Pharmaceuticals Incorporated | $46.70 | 2023-2025 | Zilretta, Iovera, Exparel |
| Stryker Corporation | $45.64 | 2019 | |
| Ethicon US, LLC | $37.38 | 2024-2025 | Stratafix, Vistaseal, Monocryl |
| Orthalign INC | $31.91 | 2024 | Orthalign Plus |
| Heron Therapeutics, INC. | $31.44 | 2023 | Zynrelef |
| Vertex Pharmaceuticals Incorporated | $28.19 | 2025 | |
| Mallinckrodt Enterprises LLC | $24.27 | 2019 | |
| Integra Lifesciences Corporation | $22.57 | 2023 | Tenoglide |
| Endo Pharmaceuticals INC. | $18.92 | 2023 | Xiaflex |
| Cumberland Pharmaceuticals, INC. | $17.70 | 2020 | |
| Medartis INC. | $17.60 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $17.19 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.62 | 2023 | Xarelto |
| Sanofi-Aventis U.S. LLC | $13.63 | 2019 | |
| Depuy Synthes Sales INC. | $12.77 | 2021 | |
| Heraeus Medical, LLC. | $12.58 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bert Hepner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.